Zobrazeno 1 - 10
of 422
pro vyhledávání: '"H, Zureikat"'
Autor:
Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the Pancreatic Neuroendocrine Disease Alliance (PANDA)
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 2, p e277 (2023)
Externí odkaz:
https://doaj.org/article/8e6751d51c704aae9a48f609c79ae263
Autor:
Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, MD, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the PAncreatic Neuroendocrine Disease Alliance (PANDA)
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 1, p e245 (2023)
Externí odkaz:
https://doaj.org/article/9a8b37a9595145f3be2cd1fe113068f9
Autor:
Samer S. AlMasri, Mazen S. Zenati, Annissa Desilva, Ibrahim Nassour, Brian A. Boone, Aatur D. Singhi, David L. Bartlett, Lance A. Liotta, Virginia Espina, Patricia Loughran, Michael T. Lotze, Alessandro Paniccia, Herbert J. Zeh III, Amer H. Zureikat, Nathan Bahary
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7233-7241 (2021)
Abstract Introduction Preoperative autophagy inhibition with hydroxychloroquine (HCQ) in combination with gemcitabine in pancreatic adenocarcinoma (PDAC) has been shown to be safe and effective in inducing a serum biomarker response and increase rese
Externí odkaz:
https://doaj.org/article/22bcc880a5264081a326a90968f1c5d6
Autor:
Naomi Fei, Sijin Wen, Rajesh Ramanathan, Melissa E. Hogg, Amer H. Zureikat, Michael T. Lotze, Nathan Bahary, Aatur D. Singhi, Herbert J. Zeh, Brian A. Boone
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1822-1829 (2021)
Abstract SMAD4, a tumor suppressor gene, is lost in up to 60%–90% of pancreatic adenocarcinomas (PDAs). Loss of SMAD4 allows tumor progression by upregulating autophagy, a cell survival mechanism that counteracts apoptosis and allows intracellular
Externí odkaz:
https://doaj.org/article/fc1b523b0b3a44e2a592d00a88565d98
Autor:
Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Takahito Yagi, Toshiyoshi Fujiwara, Amer H. Zureikat, Melissa E. Hogg, Bas Groot Koerkamp
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-7 (2021)
Abstract Background Growing evidence for the advantages of robotic pancreatoduodenectomy (RPD) has been demonstrated internationally. However, there has been no structured training program for RPD in Japan. Herein, we present the surgical training mo
Externí odkaz:
https://doaj.org/article/b19afc4a173245c888ad4dc12dc6ccb8
Autor:
Abdulrahman Y. Hammad, Hussein H. Khachfe, Samer AlMasri, Annissa DeSilva, Hao Liu, Ibrahim Nassour, Kenneth Lee, Amer H. Zureikat, Alessandro Paniccia
Publikováno v:
Journal of Gastrointestinal Surgery. 27:716-723
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbd21e1fd4bb89a5ad6adaf68f711502
https://doi.org/10.1007/s11605-023-05581-4
https://doi.org/10.1007/s11605-023-05581-4
Autor:
Jason B. Liu, Vernissia Tam, Mazen S. Zenati, Danielle Schwartz, Areej Ali, Carissa A. Low, Lillian J. Smith, Herbert J. Zeh, Amer H. Zureikat, Melissa E. Hogg
Publikováno v:
HPB. 24:1659-1667
Robotic-assisted pancreatectomy continues to proliferate despite limited evidence supporting its benefits from the patient's perspective. We compared patient-reported outcomes (PROs) between patients undergoing robotic and open pancreatectomies.PROs,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6eba11d9a811a087625429a2ce27459
https://doi.org/10.1016/j.hpb.2022.04.008
https://doi.org/10.1016/j.hpb.2022.04.008
Autor:
Amr I. Al Abbas, Ahmad B. Hamad, Mazen S. Zenati, Amer H. Zureikat, Herbert J. Zeh, Melissa E. Hogg
Publikováno v:
HPB. 24:1770-1779
Pancreatoduodenectomy (PD) remains associated with significant complication and readmission rates. Infection constitutes a significant proportion of morbidity. We aim to evaluate whether CT scans performed prior to discharge for suspected infection p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd9102d1ff9cb5cb286ca0cdb43f4c7a
https://doi.org/10.1016/j.hpb.2022.06.012
https://doi.org/10.1016/j.hpb.2022.06.012
Autor:
Louisa, Bolm, Martina, Nebbia, Alice C, Wei, Amer H, Zureikat, Carlos, Fernández-Del Castillo, Jian, Zheng, Alessandra, Pulvirenti, Ammar A, Javed, Yurie, Sekigami, Natalie, Petruch, Motaz, Qadan, Keith D, Lillemoe, Jin, He, Cristina R, Ferrone
Publikováno v:
Annals of surgery. 276(3)
The role of parenchyma-sparing resections (PSR) and lymph node dissection in small (3 cm) nonfunctional pancreatic neuroendocrine tumors (PNET) is unlikely to be studied in a prospective randomized clinical trial. By combining data from 4 high-volume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae203969a764b3a5249fe29538e9c47d
https://pubmed.ncbi.nlm.nih.gov/35758433
https://pubmed.ncbi.nlm.nih.gov/35758433
Autor:
Ammar A, Javed, Alessandra, Pulvirenti, Samrah, Razi, Jian, Zheng, Theodoros, Michelakos, Yurie, Sekigami, Elizabeth, Thompson, David S, Klimstra, Vikram, Deshpande, Aatur D, Singhi, Matthew J, Weiss, Christopher L, Wolfgang, John L, Cameron, Alice C, Wei, Amer H, Zureikat, Cristina R, Ferrone, Jin, He
Publikováno v:
Annals of surgery.
To identify factors associated with concordance between World Health Organization (WHO) grade on cytological analysis (c-grade) and histopathological analysis (h-grade) of surgical specimen in patients with PanNETs and examine trends in utilization a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1a2a3499b668cb780203399f62dcd6
https://pubmed.ncbi.nlm.nih.gov/35081574
https://pubmed.ncbi.nlm.nih.gov/35081574